Immunome Inc. - IMNM

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
May 15, 2026 SCHEDULE 13G/A Point72 Asset Management, L.P. 0.0% 0 View
May 15, 2026 SCHEDULE 13G/A Point72 Capital Advisors, Inc. 0.0% 0 View
May 15, 2026 SCHEDULE 13G/A Steven A. Cohen 0.0% 0 View
May 15, 2026 SCHEDULE 13G/A Redmile Group, LLC 4.9% 5,558,885 View
May 15, 2026 SCHEDULE 13G/A Jeremy C. Green 4.9% 5,558,885 View
May 15, 2026 SCHEDULE 13G/A T. Rowe Price Investment Management, Inc. 14.5% 16,364,011 View
May 15, 2026 SCHEDULE 13G Sirenia Capital Management LP 6.1% 6,895,000 View
May 15, 2026 SCHEDULE 13G Alex Silverstein 6.1% 6,895,000 View
Mar 26, 2026 SCHEDULE 13G/A The Vanguard Group 0.0% 0 View
Feb 17, 2026 SCHEDULE 13G/A Redmile Group, LLC 5.2% 5,718,385 View
Feb 17, 2026 SCHEDULE 13G/A Jeremy C. Green 5.2% 5,718,385 View
Dec 22, 2025 SCHEDULE 13D/A View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.